Immunosuppressive Strategies that are Mediated by Tumor Cells

  • Rabinovich G
  • Gabrilovich D
  • Sotomayor E
  • 625


    Mendeley users who have this article in their library.
  • 953


    Citations of this article.


Despite major advances in understanding the mechanisms leading to tumor immunity, a number of obstacles hinder the successful trans-lation of mechanistic insights into effective tumor immunotherapy. Such obstacles include the ability of tumors to foster a tolerant mi-croenvironment and the activation of a plethora of immunosuppres-sive mechanisms, which may act in concert to counteract effective immune responses. Here we discuss different strategies employed by tumors to thwart immune responses, including tumor-induced im-pairment of antigen presentation, the activation of negative costim-ulatory signals, and the elaboration of immunosuppressive factors. In addition, we underscore the influence of regulatory cell popula-tions that may contribute to this immunosuppressive network; these include regulatory T cells, natural killer T cells, and distinct sub-sets of immature and mature dendritic cells. The current wealth of preclinical information promises a future scenario in which the synchronized blockade of immunosuppressive mechanisms may be effective in combination with other conventional strategies to over-come immunological tolerance and promote tumor regression.

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • Gabriel A. Rabinovich

  • Dmitry Gabrilovich

  • Eduardo M. Sotomayor

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free